Cardiopulmonary diseases specialist Liquidia saw an 11% rise in its stock after the US Supreme Court denied United ...

US antivirals specialist Gilead Sciences has released additional data from its pivotal Phase III PURPOSE 2 trial providing an ...

With its recent US Food and Drug Administration (FDA) approval, Eli Lilly’s Ebglyss (lebrikizumab) adds a new competitor to ...

Germany’s Eckert & Ziegler has signed a global clinical supply agreement with Australian firm GlyTherix, providing GMP-grade ...

US clinical-stage biotech OnKure Therapeutics has announced the completion of its previously announced merger with Reneo ...

Novo Nordisk (NOV: N) has reached a settlement with Mylan Pharmaceuticals, part of Viatris (Nasdaq: VTRS), concluding a US ...

ViiV Healthcare, a GSK-majority-owned HIV specialist, has committed to making at least two million doses of its long-acting ...

Texas Attorney General Ken Paxton has filed a lawsuit against pharmaceutical companies, including Eli Lilly, and pharmacy ...

Orum Therapeutics, specializing in degrader-antibody conjugates, has filed for a $67 million IPO on South Korea's Kosdaq. The ...

Orchard Therapeutics has partnered with Turkish drugmaker Er-Kim for the exclusive distribution of its gene therapy, Libmeldy ...

Cambridge, USA-based biotech Judo Bio has announced the company’s launch and $100 million in initial financing, including ...

South Korea’s ABL Bio Corp (KS: 298380) on Friday revealed that it has entered into a clinical trial collaboration and supply ...